Description
Thiscompoundisadealkylatedmetaboliteofatazanavir,anHIVproteaseinhibitorthatexhibitsantiviralactivity.
Thiscompoundisadealkylatedmetaboliteofatazanavir,anHIVproteaseinhibitorthatexhibitsantiviralactivity.
| CasNo. | 1192224-24-0 |
|---|---|
| Purity | ≥98% |
| Formula | C26H43N5O7 |
| FormulaWt. | 537.66 |
| IUPACName | Methyl[(5S,10S,11S,14S)-11-benzyl-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | D1872InfoSheetPDF |
|---|---|
| Brochures | AntiviralsBooklet |
terHeineR,HillebrandMJ,RosingH,etal.Identificationandprofilingofcirculatingmetabolitesofatazanavir,aHIVproteaseinhibitor.DrugMetabDispos.2009Sep;37(9):1826-40.PMID:19546238.